MET
43
6
EXC
58
-2
PFE
33
10
ACN
29
-2
DUK
45
3
WU
42
-10
A
46
2
GME
62
-2
SEE
48
4
MU
50
-4
EQR
62
-2
HPE
10
-6
OKE
56
-3
MRO
40
-2
PX
19
3
DE
30
-2
DLTR
42
2
FSLR
57
2
NOV
48
3
HAS
49
-4
MET
43
6
EXC
58
-2
PFE
33
10
ACN
29
-2
DUK
45
3
WU
42
-10
A
46
2
GME
62
-2
SEE
48
4
MU
50
-4
EQR
62
-2
HPE
10
-6
OKE
56
-3
MRO
40
-2
PX
19
3
DE
30
-2
DLTR
42
2
FSLR
57
2
NOV
48
3
HAS
49
-4
Financhill
Back

BridgeBio Pharma 10K Form

Sell
46

BBIO
BridgeBio Pharma

Last Price:
27.29
Seasonality Move:
32.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BBIO News And Ratings

See the #1 stock for the next 7 days that we like better than BBIO

BBIO Financial Statistics

Sales & Book Value

Annual Sales: $9.3M
Cash Flow: $-125.25M
Price / Cash Flow: 0
Annual Sales: $-7.73
Price / Book: 0

Profitability

EPS (TTM): -3.94000
Net Income (TTM): $-643.2M
Gross Margin: $6.86M
Return on Equity: 0%
Return on Assets: -108.88%

BridgeBio Pharma Earnings Forecast

Key BridgeBio Pharma Financial Ratios

  • The Gross Profit Margin over the past 7 years for BBIO is 73.71%.
  • The Selling, General & Administrative Expenses for BBIO have been equal to 1,618.73% of Gross Profit Margin.
  • The Research & Development expenses have been 4,898.54% of Revenue.
  • The Interest Expense is -12.64% of Operating Income.
  • The Net Earning history of BBIO is -6,913.92% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

BridgeBio Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BBIO
CUSIP: 10806X
Website: bridgebio.com

Debt

Debt-to-Equity Ratio: -1.28
Current Ratio: 3.32
Quick Ratio: 3.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BBIO Technical Analysis vs Fundamental Analysis

Sell
46
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma a Buy or a Sell?

  • BridgeBio Pharma stock is rated a Sell
    The current BridgeBio Pharma [BBIO] share price is $27.02. The Score for BBIO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.